Novo Nordisk Completes Phase 3a Trials Comparing Faster-Acting Insulin, Both Trials Achieved Primary Objectives, Treatment Non-Inferior To Novorapid
March 25, 2015 at 13:26 PM EDT
Novo Nordisk today announced headline results from the final phase 3a trials for faster-acting insulin aspart, onset^® 1 and onset^® ...
